These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10053199)

  • 1. Sublingual absorption of leuprolide: comparison between human and animal models.
    Qiu Y; Johnson HW; Reiland TL; Lu MY
    Int J Pharm; 1999 Mar; 179(1):27-36. PubMed ID: 10053199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
    Lim CN; Salem AH
    Clin Pharmacokinet; 2015 Sep; 54(9):963-73. PubMed ID: 25791895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.
    Pathak AS; Pacificar JS; Shapiro CE; Williams SG
    J Urol; 2007 Jun; 177(6):2132-5; discussion 2135. PubMed ID: 17509298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of formulation adjuvants on gastrointestinal absorption of leuprolide acetate.
    Adjei A; Love S; Johnson E; Diaz G; Greer J; Haviv F; Bush E
    J Drug Target; 1993; 1(3):251-8. PubMed ID: 8069567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer.
    Mostafa NM; Chwalisz K; Larsen L; Mattia-Goldberg C; Spitz A; Pradhan RS
    Clin Pharmacol Drug Dev; 2014 Jul; 3(4):270-5. PubMed ID: 27128832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of depot leuprorelin.
    Periti P; Mazzei T; Mini E
    Clin Pharmacokinet; 2002; 41(7):485-504. PubMed ID: 12083977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
    Cox MC; Scripture CD; Figg WD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references.
    Leitner JM; Mayr FB; Spiel AO; Firbas C; Savulsky C; Mis R; Corrado ME; Jilma B
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):407-14. PubMed ID: 18793582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuprolide acetate: pharmaceutical use and delivery potentials.
    Teutonico D; Montanari S; Ponchel G
    Expert Opin Drug Deliv; 2012 Mar; 9(3):343-54. PubMed ID: 22335366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
    Singh S; Singh J
    Int J Pharm; 2007 Jan; 328(1):42-8. PubMed ID: 16959451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
    Okada H; Yamazaki I; Yashiki T; Shimamoto T; Mima H
    J Pharm Sci; 1984 Mar; 73(3):298-302. PubMed ID: 6425491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of low bioavailability of leuprolide acetate after percutaneous administration to rats by dissolving microneedles.
    Ito Y; Murano H; Hamasaki N; Fukushima K; Takada K
    Int J Pharm; 2011 Apr; 407(1-2):126-31. PubMed ID: 21277965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new injectable liquid crystal system for one month delivery of leuprolide.
    Ki MH; Lim JL; Ko JY; Park SH; Kim JE; Cho HJ; Park ES; Kim DD
    J Control Release; 2014 Jul; 185():62-70. PubMed ID: 24794897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro release and clinical pharmacokinetics of leuprolide from Luphere 3M Depot, a 3-month release formulation of leuprolide acetate.
    Park S; Kim DH; Kim Y; Park JH; Lee M; Song IS; Shim CK
    Drug Dev Ind Pharm; 2017 Mar; 43(3):441-447. PubMed ID: 27824264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design and development of controlled release of drugs from injectable microcapsules].
    Takada S; Ogawa Y
    Nihon Rinsho; 1998 Mar; 56(3):675-9. PubMed ID: 9549355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration.
    Sennello LT; Finley RA; Chu SY; Jagst C; Max D; Rollins DE; Tolman KG
    J Pharm Sci; 1986 Feb; 75(2):158-60. PubMed ID: 3083092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage form development, in vitro release kinetics, and in vitro-in vivo correlation for leuprolide released from an implantable multi-reservoir array.
    Prescott JH; Krieger TJ; Lipka S; Staples MA
    Pharm Res; 2007 Jul; 24(7):1252-61. PubMed ID: 17387603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer.
    Crawford ED; Sartor O; Chu F; Perez R; Karlin G; Garrett JS
    J Urol; 2006 Feb; 175(2):533-6. PubMed ID: 16406989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.